Capital Advisory Group Advisory Services, LLC Bristol Myers Squibb CO Transaction History
Capital Advisory Group Advisory Services, LLC
- $276 Million
- Q4 2024
A detailed history of Capital Advisory Group Advisory Services, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Capital Advisory Group Advisory Services, LLC holds 12,121 shares of BMY stock, worth $673,079. This represents 0.25% of its overall portfolio holdings.
Number of Shares
12,121
Previous 6,494
86.65%
Holding current value
$673,079
Previous $336,000
103.87%
% of portfolio
0.25%
Previous 0.13%
Shares
19 transactions
Others Institutions Holding BMY
# of Institutions
2,656Shares Held
1.47BCall Options Held
32.3MPut Options Held
34.9M-
Vanguard Group Inc Valley Forge, PA189MShares$10.5 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.81 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.16 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.33 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.35 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $118B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...